Clinical Trial Update: A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A [Phase 1]

View source ↗

Summary

A Phase 1 single-dose study in asthma patients to assess regional absorption and bioavailability of 100 mg GSK2190915A has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK2190915A

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED